UK +44 (0)1865 849841
Malaysia +603 2731 9335

Digital pathology and service design

Digital health solutions in general have a poor track record of being sustained once they are implemented, often resulting in abandonment of the technology. Current digital pathology and artificial intelligence (AI) deployment strategies are generally too IT-focused – the technology being the focus, rather than the people and environment into which they are being deployed. Furthermore, a focus on technology alone will also hamper the effective integration of AI tools into the diagnostic workflow.

Read More

Discovering event sustainability in Brussels

“Our biggest challenge in this new century is to take an idea that seems abstract – sustainable development – and turn it into a reality ”

Kofi Annan

To try and turn that abstract idea into something more tangible, Global Engage has joined ISLA. This is a body that is working with the events industry to accelerate its transition to a sustainable future.

Read More

Switch to digital pathology bears fruit

Fully digitising pathology operations has led to greater efficiency, cost savings, and quicker diagnosis for the Laboratory of Pathology East Netherlands (LabPON). The move, made six years ago, is showing measurable benefits and now, the institution is beginning to explore the potential of deep learning computational pathology algorithms, which might push the efficiency gains even further.

Prof Alexi Baidoshvili

Read More

What is Net Zero and what does it mean for events?

As the world considers how it can mitigate climate change, Global Engage has committed to playing its part by reducing the impact of running events. But how to do it? I recently attended an onboarding course organised by ISLA and discovered that “Carbon Neutral” and “Net Zero” are not the same thing!

Read More

Digital Pathology: The Next Hurdles

A Market on the Rise
There has clearly been a surge in interest for digital pathology adoption over the last two years

Read More

Highlights from the 9th Microbiome R&D and Business Collaboration Forum – Europe

It was clear that microbiome companies have been advancing their programs as rapidly as ever, despite the changes brought about by the global pandemic. Service providers—including drug manufacturing organizations—have been busy during the past year, as they continue actively helping diagnostics and therapeutics companies find solutions to advance their products.

Read More

Conversation with Dr Hamid Tizhoosh, Founder of KIMIA Lab and Leading Expert in the Development of Unsupervised AI for Tissue Pathology

What we have to learn from day one when we design these AI applications, is that pathology has to come with us. We cannot just design a network as computer scientists and then go to the pathologists just when we need to validate it. The pathologist has to be with us from the start.

Dr Hamid Tizhoosh

Read More

A Paradigm Change in Skin Health

There has been a rapid acceleration of skin microbiome research. Today about 5% of all microbiome clinical studies and 16% of all probiotic products online are dermatology related. Meanwhile, skin probiotics are growing eight times faster than any other probiotic supplement. In clinical cosmetic studies, the microbiome is the fourth largest category.

Read More

Subscribe to Our Newsletter

Get free reports and resources from our world class speakers.
  • This field is for validation purposes and should be left unchanged.

Archive